Manufacturer:

Baxalta

Name:

GAMMAGARD S-D

Category:

J Code

HCPCS:

J1566

NDC(s):

00944-2656-03, 00944-2658-04,

Primary Type:

Immunoglobulin

Route of Administration:

Intravenous

About:

GAMMAGARD S-D is a Immunoglobulin drug manufactured by Baxalta and administered via the Intravenous route of administration. The J Code: J1566 is aligned to the drug GAMMAGARD S-D.

Gammagard S/D is used to help protect people with weakened immune systems by increasing platelet count. Gammagard S/D can also be used to treat certain cases of muscle weakness, certain nerve disorders, and blood vessel disorders. Gammagard S/D is administered as an intravenous injection of human blood that contains a high level of antibodies. Gammagard Liquid, is a different product than Gammagard S/D. Gammagard S/D is mapped to the HCPCS J1566 while Gammagard Liquid is mapped to the HCPCS J1569. The product monograph for Gammagard S/D can be found here: https://assets-dam.takeda.com/raw/upload/v1662721788/legacy-dotcom/siteassets/en-ca/home/what-we-do/our-medicines/product-monographs/gammagard-sd/gammagard-sd-pm-en.pdf.